Veizaga Marvin 4
4 · CROSS COUNTRY HEALTHCARE INC · Filed Apr 2, 2026
Research Summary
AI-generated summary of this filing
Cross Country Healthcare (CCRN) CAO Marvin Veizaga Receives 9,043 Restricted Shares
What Happened
- Marvin Veizaga, Chief Accounting Officer of Cross Country Healthcare (CCRN), was granted 9,043 restricted shares on March 31, 2026 (award reported at $0.00). To satisfy tax withholding on restricted stock that vested that day, 938 shares were withheld and disposed (501 and 437 shares) at $9.40 per share, generating proceeds of $4,709 and $4,108 (total ~$8,817). The filing also notes 4,471 shares that were inadvertently omitted from Veizaga’s Form 3 (filed March 25, 2026) are reflected in this report.
Key Details
- Transaction date(s): March 31, 2026; Filing date: April 2, 2026.
- Award: 9,043 restricted shares acquired at $0.00 (code A).
- Tax withholding (disposals): 501 shares @ $9.40 ($4,709) and 437 shares @ $9.40 ($4,108) (code F); total withheld = 938 shares (~$8,817).
- Vesting: The 9,043 restricted shares vest in three substantially equal installments on March 31, 2027, March 31, 2028 and March 31, 2029 (footnote F1).
- Other notes: Footnote F2 reflects 4,471 shares omitted from the prior Form 3; footnote F3 confirms the withheld shares satisfied tax withholding on shares that vested March 31, 2026.
- Shares owned after transaction: Not specified in the provided filing details.
Context
- This filing primarily reports an equity award (not a purchase) and routine tax-withholding dispositions; withholding to cover taxes is common and does not by itself signal insider intent to buy or sell additional shares.
- The award vests over future dates, so the recipient does not have immediate free-trading shares from this grant.
Insider Transaction Report
Form 4
Veizaga Marvin
Chief Accounting Officer
Transactions
- Award
Common Stock
[F1][F2]2026-03-31+9,043→ 32,654 total - Tax Payment
Common Stock
[F3]2026-03-31$9.40/sh−501$4,709→ 32,153 total - Tax Payment
Common Stock
[F3]2026-03-31$9.40/sh−437$4,108→ 31,716 total
Footnotes (3)
- [F1]These restricted shares of common stock vest in three substantially equal installments. The installments will vest on March 31, 2027, March 31, 2028 and March 31, 2029.
- [F2]Reflects an additional 4,471 shares of common stock that were inadvertently omitted from the Reporting Person's Form 3 filed on March 25, 2026.
- [F3]These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2026.
Signature
/s/ Marvin Veizaga|2026-04-02